newsfilter
← Latest News
PR Newswire·

REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II

REGENXBIO Inc. (Nasdaq: RGNX) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding...